170 related articles for article (PubMed ID: 32624195)
1. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study.
Cornberg M; Pischke S; Müller T; Behrendt P; Piecha F; Benckert J; Todt D; Steinmann E; Papkalla A; von Karpowitz M; Koch A; Lohse A; Hardtke S; Manns MP; Wedemeyer H
J Hepatol; 2020 Sep; 73(3):696-699. PubMed ID: 32624195
[No Abstract] [Full Text] [Related]
2. Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.
van der Valk M; Zaaijer HL; Kater AP; Schinkel J
J Hepatol; 2017 Jan; 66(1):242-243. PubMed ID: 27702641
[No Abstract] [Full Text] [Related]
3. Chronic hepatitis E infection cured by pregnancy.
Mallet V; Le Mener S; Roque-Afonso AM; Tsatsaris V; Mamzer MF
J Clin Virol; 2013 Dec; 58(4):745-7. PubMed ID: 24140032
[No Abstract] [Full Text] [Related]
4. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
5. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
Sridhar S; Chan JFW; Yap DYH; Teng JLL; Huang C; Yip CCY; Hung IFN; Tang SCW; Lau SKP; Woo PCY; Yuen KY
J Viral Hepat; 2018 Feb; 25(2):209-213. PubMed ID: 28984015
[No Abstract] [Full Text] [Related]
6. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
Wang Y; Chen G; Pan Q; Zhao J
Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
[No Abstract] [Full Text] [Related]
7. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
[TBL] [Abstract][Full Text] [Related]
8. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
Chen S; Wei F; Wu T; Xia N
Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis in the transplant patient.
Shahid S; Rait S; Sharples E; Gorard D
Br J Hosp Med (Lond); 2017 Jul; 78(7):408-409. PubMed ID: 28692371
[No Abstract] [Full Text] [Related]
11. Hepatitis E virus: An ancient hidden enemy in Latin America.
Fierro NA; Realpe M; Meraz-Medina T; Roman S; Panduro A
World J Gastroenterol; 2016 Feb; 22(7):2271-83. PubMed ID: 26900289
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
Tavitian S; Peron JM; Huguet F; Kamar N; Abravanel F; Beyne-Rauzy O; Oberic L; Faguer S; Alric L; Roussel M; Gaudin C; Ysebaert L; Huynh A; Recher C
Emerg Infect Dis; 2015 Aug; 21(8):1466-9. PubMed ID: 26197210
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
Todt D; Meister TL; Steinmann E
Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
16. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV.
Jagjit Singh GK; Ijaz S; Rockwood N; Farnworth SP; Devitt E; Atkins M; Tedder R; Nelson M
J Infect; 2013 Jan; 66(1):103-6. PubMed ID: 22166370
[TBL] [Abstract][Full Text] [Related]
17. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
[No Abstract] [Full Text] [Related]
18. The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
Sastre L; García-López M; Pérez-Del-Pulgar S; Lens S; Costa J; Navasa M; Forns X
Gastroenterol Hepatol; 2020 Mar; 43(3):136-137. PubMed ID: 31902599
[No Abstract] [Full Text] [Related]
19. [Hepatitis E: an emerging viral disease].
Soriano V; Barreiro P
Med Clin (Barc); 2014 Jul; 143(1):22-4. PubMed ID: 24656852
[No Abstract] [Full Text] [Related]
20. Clinical features and determinants of chronicity in hepatitis E virus infection.
Narayanan S; Abutaleb A; Sherman KE; Kottilil S
J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
